** Please note this program was featured in OPSC's 35th Annual Fall Conference, CME by the Bay 2024, held in Monterey, California. If you attended this event in person or purchased the digital edition, you will not qualify for CME credits by participating in the program. **
New evidence, as released in the April 2024 edition of "Menopause" has demonstrated several major health benefits of HRT for women over the age of 65. These include a REDUCTION in rates of breast, ovarian, endometrial, colorectal and lung cancers, as well as a decrease in cardiovascular events, AMI, AFib, and even dementia. It would be of benefit to the primary care and specialty providers of this forum to be introduced to this enlightening data, to be better equipped to counsel their patients about the potential health benefits of HRT in relation to overall longevity and Healthspan.
Learning Objectives:
- Understand the health benefits of HRT in women over the age of 65 based on current evidence.
- Improve understanding of health-related morbidities and mortality associated with menopause.
- Improve understanding of the overall benefits of HRT for tissue integrity and organ systems beyond climacteric symptoms.
- Understand differences in dosing and route of administration of synthetic vs bioidentical hormone therapy.
Disclosures: None Reported
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Osteopathic Physicians and Surgeons of California (OPSC) is accredited by the AOA to provide osteopathic continuing medical education for physicians.
Grievance Policy: Osteopathic Physicians and Surgeons of California (OPSC) strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to OPSC, by calling the OPSC Office at (916) 822-5246 or by email at opsc@opsc.org.
